NCT07830745

Brief Summary

The goal of this clinical trial is to investigate whether optokinetic stimulation delivered without a reading task can improve reading performance in adults with post-stroke hemianopic alexia. The main question it aims to answer is: does optokinetic stimulation without a reading task improve reading speed more than optokinetic stimulation with a reading task? Optokinetic stimlation with a reading task is considered the standard rehabilitation. These two conditions will be administered according to a randomized crossover design to determine wether the presence or absence of a reading task influences reading outcomes. Participants will

  • receive 4 weeks of optokinetic stimulation without a reading task and 4 weeks of optokinétic stimulation with a reading task, with the order of these two interventions determined by randomization,
  • undergo assesments of reading performance, oculomotor behavior, visual field and rehabilitation tolerability before and after each intervention period,
  • undergo a follow-up assesment 1 month after completion of the interventions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Jun 2027

First Submitted

Initial submission to the registry

September 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

8 months

First QC Date

September 15, 2026

Last Update Submit

September 15, 2026

Conditions

Keywords

Homonymous hemianopiaReading rehabilitationHemianopic alexiaOptokineticOcular mobility

Outcome Measures

Primary Outcomes (1)

  • Change in reading speed on paper

    Change in the number of correctly read words per minute, assessed using the International Reading Speed Texts (IReST). For each participant, the change in reading speed will be calculated separately for the optokinetic rehabilitation condition with a reading task and for the optokinetic rehabilitation condition without a reading task. The within-participant changes obtained after each 4-week period will be pooled across the two randomized sequences and compared between conditions. A higher reading speed indicates better reading performance.

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

Secondary Outcomes (11)

  • Change in reading accuracy on paper

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  • Change in reading speed on screen

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  • Change in reading accuracy on screen

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  • Change in subjective reading abilities

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  • Change in ocular fixations during reading

    Baseline and end of each 4-week rehabilitation period: Week 0, Week 4, and Week 8

  • +6 more secondary outcomes

Study Arms (2)

Group A

OTHER

Patients receive 15 sessions of optokinetic rehabilitation with a reading task, followed by 15 sessions of optokinetic rehabilitation without an associated reading task. The optokinetic rehabilitation sessions with reading are considered the standard of care, while optokinetic rehabilitation without an associated reading task is the experimental condition. Each patient undergoes both conditions sequentially and serves as their own control.

Other: Optokinetic stimulation without reading taskOther: Optokinetic stimulation with reading task

Group B

OTHER

Patients receive 15 sessions of optokinetic rehabilitation without an associated reading task, followed by 15 sessions of optokinetic rehabilitation with a reading task. The optokinetic rehabilitation sessions with reading are considered the standard of care, while optokinetic rehabilitation without an associated reading task is the experimental condition. Each patient undergoes both conditions sequentially and serves as their own control.

Other: Optokinetic stimulation without reading taskOther: Optokinetic stimulation with reading task

Interventions

Participants are exposed to a horizontally moving optokinetic visual stimulus on a computer screen for 40 minutes per session. The task consists of viewing random sequences of letters scrolling from right to left. The sessions are spread out over 4 weeks, with 3 or 4 sessions per week, to achieve 10 hours (15 sessions) of optokinetic rehabilitation.

Group AGroup B

Participants are exposed to a horizontally moving optokinetic visual stimulus on a computer screen for 40 minutes per session. The task consists of reading aloud sentences scrolling from right to left. The sessions are spread out over 4 weeks, with 3 or 4 sessions per week, to achieve 10 hours (15 sessions) of optokinetic rehabilitation. The scrolling speed ranges from 85 to 275 words per minute, depending on the participant's reading accuracy.

Group AGroup B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Time since lesion \> 1 month
  • Diagnosis of homonymous hemianopia post-stroke without macular sparing
  • Reading complaint and/or reading impairment
  • Proficiency in reading French
  • Agreed to give informed consent
  • Afiliated with national health insurance

You may not qualify if:

  • History of neurological or psychiatric disorders
  • Visual impairment of peripheral origin (i.e., related to damage to the structures of the eye or the optic nerve)
  • Uncorrected visual acuity deficit
  • Reading disorder prior to the stroke (dyslexia)
  • Instability of reading impairment
  • Instability of homonymous hemianopia
  • Major cognitive that would limit the ability of the patient to participate in the study (unilateral spatial neglect, simultanagnosia, comprehension disorder, oral expression disorder)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Les Trois Soleils

Boissise-le-Roi, Île-de-France Region, 77310, France

Location

Related Publications (4)

  • Goodwin D. Homonymous hemianopia: challenges and solutions. Clin Ophthalmol. 2014 Sep 22;8:1919-27. doi: 10.2147/OPTH.S59452. eCollection 2014.

    PMID: 25284978BACKGROUND
  • Schuett S, Heywood CA, Kentridge RW, Zihl J. Rehabilitation of hemianopic dyslexia: are words necessary for re-learning oculomotor control? Brain. 2008 Dec;131(Pt 12):3156-68. doi: 10.1093/brain/awn285. Epub 2008 Nov 3.

    PMID: 18984602BACKGROUND
  • Zihl J. Eye movement patterns in hemianopic dyslexia. Brain. 1995 Aug;118 ( Pt 4):891-912. doi: 10.1093/brain/118.4.891.

    PMID: 7655887BACKGROUND
  • Spitzyna GA, Wise RJ, McDonald SA, Plant GT, Kidd D, Crewes H, Leff AP. Optokinetic therapy improves text reading in patients with hemianopic alexia: a controlled trial. Neurology. 2007 May 29;68(22):1922-30. doi: 10.1212/01.wnl.0000264002.30134.2a.

    PMID: 17536049BACKGROUND

MeSH Terms

Conditions

HemianopsiaStroke

Condition Hierarchy (Ancestors)

Vision DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesBlindnessEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Christophe Duret

    Clinique Les Trois Soleils, Boissise-le-Roi, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Clotilde Guillerot

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2026

First Posted

September 21, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

September 21, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations